Your browser doesn't support javascript.
loading
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.
Lee, Craig R; Luzum, Jasmine A; Sangkuhl, Katrin; Gammal, Roseann S; Sabatine, Marc S; Stein, Charles Michael; Kisor, David F; Limdi, Nita A; Lee, Yee Ming; Scott, Stuart A; Hulot, Jean-Sébastien; Roden, Dan M; Gaedigk, Andrea; Caudle, Kelly E; Klein, Teri E; Johnson, Julie A; Shuldiner, Alan R.
Afiliação
  • Lee CR; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
  • Luzum JA; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
  • Sangkuhl K; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
  • Gammal RS; Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA.
  • Sabatine MS; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Stein CM; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Kisor DF; Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Limdi NA; Department of Pharmaceutical Sciences, Manchester University, Fort Wayne, Indiana, USA.
  • Lee YM; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Scott SA; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
  • Hulot JS; Department of Pathology, Stanford University, Stanford, California, USA.
  • Roden DM; Clinical Genomics Laboratory, Stanford Health Care, Palo Alto, California, USA.
  • Gaedigk A; Université de Paris, CIC1418 and DMU CARTE, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France.
  • Caudle KE; Departments of Medicine and Pharmacology, Office of Personalized Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Klein TE; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City and University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
  • Johnson JA; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Shuldiner AR; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
Clin Pharmacol Ther ; 112(5): 959-967, 2022 11.
Article em En | MEDLINE | ID: mdl-35034351
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Pró-Fármacos Tipo de estudo: Guideline Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Pró-Fármacos Tipo de estudo: Guideline Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos